ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,224.05
0.70%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Disc Medicine Inc (IRON)

  7. Disc Medicine Inc (IRON) News

Disc Medicine (IRON)

Disc Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IRON
DateTimeSourceHeadlineSymbolCompany
09/05/202413:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRONDisc Medicine Inc
09/05/202413:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
09/05/202413:00GlobeNewswire Inc.Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
01/04/202413:00GlobeNewswire Inc.Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)NASDAQ:IRONDisc Medicine Inc
21/03/202412:00GlobeNewswire Inc.Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
06/03/202421:30GlobeNewswire Inc.Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024NASDAQ:IRONDisc Medicine Inc
02/03/202400:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/03/202400:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/03/202400:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/03/202400:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
26/02/202413:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
26/02/202413:30GlobeNewswire Inc.Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial OfficerNASDAQ:IRONDisc Medicine Inc
20/02/202413:30GlobeNewswire Inc.Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseNASDAQ:IRONDisc Medicine Inc
15/02/202421:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
13/02/202423:51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IRONDisc Medicine Inc
09/02/202414:00GlobeNewswire Inc.Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia VeraNASDAQ:IRONDisc Medicine Inc
07/02/202413:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
07/02/202413:00GlobeNewswire Inc.Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating OfficerNASDAQ:IRONDisc Medicine Inc
06/02/202421:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
23/01/202422:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
04/01/202421:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
03/01/202422:00GlobeNewswire Inc.Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IRONDisc Medicine Inc
03/01/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
02/01/202421:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
29/12/202321:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
20/12/202321:30GlobeNewswire Inc.Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory BoardNASDAQ:IRONDisc Medicine Inc
14/12/202321:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
12/12/202321:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
12/12/202301:30GlobeNewswire Inc.Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:IRONDisc Medicine Inc
11/12/202317:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:IRON

Your Recent History

AMEX
MDY
SPDR S&P MIDCAP 400
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved